Methods for the manufacture of recombinant viral vectors
US12398403B2 · kind B2 · utility
0Cited by
1References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 26, 2020 |
| Grant date | Aug 26, 2025 |
| Priority date | — |
| Expiry date | Aug 28, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N15/86
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to methods for the production of high titer recombinant viral vectors, more particularly recombinant AAV vectors, so that the methods can be effectively employed on a scale that is suitable for the practical application of gene therapy techniques.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.